Sublingual naloxone spray
US9642848B2 · kind B2 · utility
16Cited by
11References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2015 |
| Grant date | May 9, 2017 |
| Priority date | — |
| Expiry date | Jun 4, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides storage stable sublingual formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering the sublingual formulations of the present invention to a patient in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.